Biogen’s Alzheimer’s Drug Slows Mental Decline in Early Study

  (Reuters) – An experimental drug from Biogen Idec Inc became the first Alzheimer’s treatment to significantly slow cognitive decline and reduce what is believed to be brain-destroying plaque in patients with early and mild forms of the disease, according to a small study likely Read More